Dietary Supplement Ads May Influence FDA Conclusion On Disease Claims
This article was originally published in The Tan Sheet
Executive Summary
FDA may consider dietary supplement advertising when determining whether marketing statements for a product constitute inappropriate disease claims, FDA Office of Special Nutritionals Special Assistant Christine Lewis, PhD, commented at the Food & Drug Law Institute annual conference in Washington, D.C. Dec. 16-17.